Investors in orthopedics traditionally have backed companies with technologies compelling enough to draw the interest of giants on the industry’s mountaintop—Medtronic Inc. ’s Medtronic Sofamor Danek , Johnson & Johnson ’s Depuy Spine Inc. , Synthes-Stratec ’s Synthes USA , Stryker Corp., and Zimmer Spine (a division of Zimmer Holdings Inc.’s Centerpulse AG)--controllers of 70% of the $4.3 billion US spine market. (See "The Hot Trend in Spine: Motion Preservation Mania," Medtech Insight, June 2007 Also see "The Hot Trend in Spine: Motion Preservation Mania" - Medtech Insight, 1 June, 2007..)
Globus Prepared for Trek with $110m from Clarus-led Group
Clarus Ventures placed an unusually big bet for the orthopedics industry by leading a syndicate of private equity investors in a $110 million Series E round in Globus Medical Inc. But the four-year-old company is well ahead of its peers with more than $100 million in sales and a line of fusion products on the market. The company faces the challenge of introducing a new line of non-fusion and biomaterial products if it hopes to grow into the industry leader its investors expects it to be.